(Q61682918)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21276607%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Activation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21276607%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21276607%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Yong-Tark Jeon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21276607%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

In-Ae Park

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21276607%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Yong-Beom Kim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21276607%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Jae Weon Kim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21276607%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Noh-Hyun Park

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21276607%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Soon-Beom Kang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21276607%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Jae Yong Han

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21276607%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Jeong Mook Lim

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21276607%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Yong-Sang Song

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21276607%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

English

0 references

publication date

26 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21276607%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21276607%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21276607%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21276607%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

8-12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21276607%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.364

Beyond chemotherapy: targeted therapies in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.364

The TOR pathway: a target for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.364

mTOR, translation initiation and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.364

AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.364

HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.364

Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.364

eIF4E--from translation to transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.364

Activated eIF4E-binding Protein Slows G1 Progression and Blocks Transformation by c-myc without Inhibiting Cell Growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.364

Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.364

RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.364

Bevacizumab and rapamycin inhibit tumor growth in peritoneal model of human ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.364

4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.364

Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.364

Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.364

Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.364

Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.364

Upstream and downstream of mTOR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.364

Multiple mechanisms control phosphorylation of PHAS-I in five (S/T)P sites that govern translational repression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.364

A nuclear transport signal in mammalian target of rapamycin is critical for its cytoplasmic signaling to S6 kinase 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.364

The role of mTOR and phospho-p70S6K in pathogenesis and progression of gastric carcinomas: an immunohistochemical study on tissue microarray

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.364

Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.364

10.1016/J.YGYNO.2010.12.364

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21276607%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference